Vinorelbine
Navelbine (vinorelbine) is a small molecule pharmaceutical. Vinorelbine was first approved as Navelbine on 1994-12-23. It is used to treat breast neoplasms, hodgkin disease, non-small-cell lung carcinoma, and ovarian neoplasms in the USA.
| Trade Name | Navelbine |
|---|---|
| Common Name | Vinorelbine |
| Indication | breast neoplasms, hodgkin disease, non-small-cell lung carcinoma, ovarian neoplasms |
| Drug Class | Vinca alkaloids |
